Bacterial disease in HIV-infected patients: The blind spot of highly active antiretroviral therapy? [3]

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 4, 2006, Pages 532-535

  Noursadeghi, Mahdad ^a   Ustianowski, Andrew ^a,b   Elgalib, Ali ^a   Miller, Robert ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

BACTERIAL ARTHRITIS; BACTERIAL INFECTION; CD4 LYMPHOCYTE COUNT; ENDOCARDITIS; GASTROENTERITIS; HEPATOBILIARY DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LETTER; MENINGITIS; NONHUMAN; OPPORTUNISTIC INFECTION; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PYELONEPHRITIS; SEPTICEMIA; SOFT TISSUE INFECTION; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; UROGENITAL TRACT INFECTION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTERIAL INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 33646810133     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000209912.17695.e5     Document Type: Letter

References (17)

1. Florence E, Bottieau E, Lynen L, et al. Patients with HIV infection and fever: a diagnostic approach. Acta Clin Belg. 2002;57:184-190.
2. Sullivan M, Feinberg J, Bartlett JG. Fever in patients with HIV infection. Infect Dis Clin North Am. 1996;10:149-165.
3. Pitkin AD, Grant AD, Foley NM, et al. Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-1987 and 1990-1991. Thorax. 1993;48:204-207.
4. Miller RF, Hingorami AD, Foley NM. Pyrexia of undetermined origin in patients with human immunodeficiency virus infection and AIDS. Int J STD AIDS. 1996;7:170-175.
5. Miller RF, Hall-Craggs MA, Costa DC, et al. Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. Sex Transm Infect. 1998;74:258-264.
6. Lopez Bernaldo de Quiros JC, Miro JM, Pena JM, et al. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98. N Engl J Med. 2001;344:159-167.
7. Pedro-Botet ML, Modol JM, Valles X, et al. Changes in bloodstream infections in HIV-positive patients in a university hospital in Spain (1995-1997). Int J Infect Dis. 2002;6:17-22.
8. Berger BJ, Hussain F, Roistacher K. Bacterial infections in HIV-infected patients. Infect Dis Clin North Am. 1994;8:449-465.
9. Gilks CF. Acute bacterial infections and HIV disease. Br Med Bull. 1998;54:383-393.
10. Madhi SA, Petersen K, Madhi A, et al. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis. 2000;31:170-176.
11. World Health Organization. Acquired immunodeficiency syndrome (AIDS). Wkly Epidemiol Rec. 1990;65:329-331.
12. Janoff EN, Breiman RF, Daley CL, et al. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med. 1992;117:314-324.
13. Md VN, Md PK. Bacterial infections in adult HIV-infected patients. HIV Clin Trials. 2005;6:213-228.
14. Heffernan RT, Barrett NL, Gallagher KM, et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis. 2005;191:2038-2045.
15. Jordano Q, Falco V, Almirante B, et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis. 2004;38:1623-1628.
16. Benito N, Rano A, Moreno A, et al. Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain. J Acquir Immune Defic Syndr. 2001;27:35-43.
17. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 2002;111:927-930.